OVID · Ovid Therapeutics Inc. · Debt
$2.42
+0.04 (+1.68%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$468.71M
Shares
195.30M
Volume · Oct 5
1.19M
Avg daily vol (3M)
1.63M
Debt Profile
Processing began with filings dated Mar 18, 2026 · latest terminal result Mar 18, 2026Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 1,484,000 | 10-Q filed 2026-08-13 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 11,231,000 | 10-Q filed 2026-08-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.